Cresp 40 Injection
Marketer
Dr Reddy's Laboratories Ltd
Salt Composition
Darbepoetin alfa (40mcg)
Overview Cresp 40 Injection
Erythropoietin injection, Cresp 40, treats anemia resulting from chronic kidney disease or chemotherapy. Its mechanism involves bone marrow stimulation for increased red blood cell production. Administered under medical supervision, Cresp 40 necessitates careful use due to potential serious adverse reactions. Expert medical guidance is crucial; patients must adhere strictly to prescribed instructions. Common side effects comprise abdominal discomfort, hypertension, skin rash, injection site pain, dyspnea, cough, and peripheral swelling. Report symptoms of severe hypertension, including intense headache, visual disturbances, nausea, vomiting, or convulsions, immediately. Regular blood tests to monitor electrolyte levels (potassium), hemoglobin, and blood cell counts are typically conducted. Discontinue use and seek medical attention if shortness of breath or a skin eruption develops. Prior to commencing treatment, disclose any history of cardiac disease, hypertension, seizures, or strokes. Pregnant, breastfeeding, or intending to become pregnant or breastfeed patients should consult their physician regarding its safety.
Primary Ingredients of Cresp 40 Injection
There is no text provided to rephrase.
Uses of Cresp 40 Injection
Managing anemia in chronic kidney disease patients | Addressing chemotherapy-induced anemia
Major Benefits of Cresp 40 Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Cresp 40 Injection:
- Abdominal pain
- High blood pressure
- Rash
- Injection site pain
- Breathlessness
- Cough
- Peripheral edema
- Procedural hypotension (low blood pressure)
- Convulsion
- Thromboembolism
How to use Cresp 40 Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
How Cresp 40 Injection works:
Cresp 40 Injection is an erythropoietin-based medication that boosts red blood cell production. It acts by prompting increased red blood cell generation within the bone marrow, the blood-cell-forming tissue found inside bones.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Cresp 40 Injection may pose safety risks; seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Cresp 40 Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Administering Cresp 40 Injection while breastfeeding is likely inadvisable. Available human data indicates a potential for the medication to transfer to breast milk, posing a risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Cresp 40 Injection.
KidneySAFE IF PRESCRIBED
Cresp 40 Injection poses no safety concerns for patients with renal impairment; no dosage modification is necessary.
LiverCAUTION
Individuals with hepatic impairment should exercise prudence when administering Cresp 40 Injection. Dosage modification of Cresp 40 Injection might be necessary. Physician consultation is advised.
What if you forget to take Cresp 40 Injection :
Should you forget a Cresp 40 Injection, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Cresp 40 Injection
| Label | Value |
|---|---|
| Chemical Type | Amino Acid and Peptide Analogs |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Behavioral Class | Erythropoietin-stimulating drug |
3,018 People bought this recently